Seller record · Telehealth service

Pepti

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Passes all 8 criteria checked against Standard v1.1.

At a glance

PeptiTelehealth service

8/8criteria passed
Price
Semaglutide from $99, tirzepatide from $159 a month
Sells
compounded semaglutide, compounded tirzepatide, sermorelin, and 12 more
FDA letters
None on file
Visit PeptiSee all eight dispositions

Telehealth service. Passes 8 of 8 criteria. Recorded against Standard v1.1.

A peptide telehealth service selling compounded semaglutide and tirzepatide beside sermorelin, NAD+, GHK-Cu, glutathione, PT-141, BPC-157, TB-500, tesamorelin and several dozen other peptides and blends. It publishes laboratory results for individual lots, naming the compounding pharmacy and the testing laboratory.

Operating entity pepti LLC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSPepti's semaglutide product page; Pepti's providers page
S2Prescription gatingPASSPepti's assessment page; Pepti's how it works page
S3Pharmacy identificationPASSPepti's pharmacy fulfillment page; Pepti's quality page; Pepti's 090726 sem B12 2.5 product page
S4Compounding disclosurePASSPepti's semaglutide product page; Pepti's pharmacy fulfillment page
S5Analytical documentationPASSPepti's 090726 sem B12 2.5 product page; Pepti's lab results page
S6Business addressPASSPepti's website; Pepti's pharmacy fulfillment page
S7Price disclosurePASSPepti's semaglutide product page; Pepti's assessment page; Pepti's tirzepatide product page; Pepti's sermorelin product page; Pepti's NAD+ injection product page; Pepti's tesamorelin product page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed U.S. physician reviews every prescription before it is dispensed, and the product pages name the reviewing physician.Source: Pepti's semaglutide product page; Pepti's providers page.
S2PASSThe start button opens a medical intake assessment, and payment is taken only after a physician approves the plan.Source: Pepti's assessment page; Pepti's how it works page.
S3PASSThe pharmacy policy names Olympia Pharmacy as a partner, and the lot results name Kaduceus Pharmacy in Houston, Texas and Mills Pharmacy & Apothecary in Birmingham, Michigan as the compounding pharmacies.Source: Pepti's pharmacy fulfillment page; Pepti's quality page; Pepti's 090726 sem B12 2.5 product page.
S4PASSEach product page states that compounded medications are not FDA-approved or FDA-cleared, and the pharmacy policy and footer repeat it.Source: Pepti's semaglutide product page; Pepti's pharmacy fulfillment page.
S5PASSSemaglutide lot 090726-SEM-B12-2.5 is published with sterility, endotoxin and 98.2 percent potency results from Biolink Life Sciences Carolinas, dated September 2026 and transcribed from the laboratory certificate, with lot pages for each product.Source: Pepti's 090726 sem B12 2.5 product page; Pepti's lab results page.
S6PASSpepti LLC at 131 Continental Dr, Suite 305, Newark, DE 19713, printed in the footer of every page.Source: Pepti's website; Pepti's pharmacy fulfillment page.
S7PASSCompounded semaglutide at $99 a month at the 0.25 mg starting dose, up to $199 at 2.5 mg, and compounded tirzepatide at $159 at the 2.5 mg starting dose. Sermorelin at $229 a month by vial or $299 by pen, the NAD+ injection at $249 by vial, BPC-157 at $209 by vial and tesamorelin at $249 at 10 mg.Source: Pepti's semaglutide product page; Pepti's assessment page; Pepti's tirzepatide product page; Pepti's sermorelin product page; Pepti's NAD+ injection product page; Pepti's tesamorelin product page.
S8PASSNo FDA warning letter names Pepti or the operating entity pepti LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin, NAD+ injection, GHK-Cu, glutathione, PT-141, BPC-157, TB-500, tesamorelin, ipamorelin, MOTS-c, semax, epitalon, peptide blends.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathioneWho sells PT-141Who sells GHK-CuWho sells tesamorelinWho sells BPC-157Who sells TB-500Who sells MOTS-cWho sells semaxWho sells epitalonWho sells ipamorelin

Unpaid link. Pepti does not pay the site, and nothing is earned when it is used. Funding.

Visit Pepti

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.